[go: up one dir, main page]

ATE521610T1 - Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität - Google Patents

Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität

Info

Publication number
ATE521610T1
ATE521610T1 AT04761819T AT04761819T ATE521610T1 AT E521610 T1 ATE521610 T1 AT E521610T1 AT 04761819 T AT04761819 T AT 04761819T AT 04761819 T AT04761819 T AT 04761819T AT E521610 T1 ATE521610 T1 AT E521610T1
Authority
AT
Austria
Prior art keywords
compounds
chemokine receptor
receptor activity
spir
methods
Prior art date
Application number
AT04761819T
Other languages
English (en)
Inventor
Chun Kong Laval Chan
Ming-Qiang Zhang
Christophe Moinet
Marc Courchesne
Thumkunta Reddy
Original Assignee
Virochem Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virochem Pharma Inc filed Critical Virochem Pharma Inc
Application granted granted Critical
Publication of ATE521610T1 publication Critical patent/ATE521610T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT04761819T 2003-09-10 2004-09-09 Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität ATE521610T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50140703P 2003-09-10 2003-09-10
PCT/CA2004/001656 WO2005023809A1 (en) 2003-09-10 2004-09-09 Spiro compounds and methods for the modulation of chemokine receptor activity

Publications (1)

Publication Number Publication Date
ATE521610T1 true ATE521610T1 (de) 2011-09-15

Family

ID=34273044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04761819T ATE521610T1 (de) 2003-09-10 2004-09-09 Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität

Country Status (5)

Country Link
US (1) US7288548B2 (de)
EP (1) EP1786815B1 (de)
AT (1) ATE521610T1 (de)
CA (1) CA2579608A1 (de)
WO (1) WO2005023809A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2676B1 (en) * 2004-04-06 2012-06-17 جانسين فارماسوتيكا ان. في Derivatives of second-aza-spiro- (5,4) -dikan and their use as antihistamines
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
EP1824853A4 (de) 2004-12-09 2010-06-09 Virochem Pharma Inc Neue spirotropanverbindungen und verfahren zur modulation der aktivität des chemokinrezeptors
BRPI0518859A2 (pt) 2004-12-09 2008-12-09 Virochem Pharma Inc compostos de espirotropano e mÉtodos para a modulaÇço de atividade de receptor de quimiocina
BRPI0608847A2 (pt) * 2005-03-08 2010-02-02 Janssen Pharmaceutica Nv derivados de diaza-espiro-[4,4]-nonano substituìdos e seu uso como antagonistas de neurocinina
JP2012526136A (ja) * 2009-05-07 2012-10-25 メルク・シャープ・エンド・ドーム・コーポレイション 抗糖尿病化合物として有用な置換スピロ環式アミン
US9828345B2 (en) 2013-02-28 2017-11-28 Bristol-Myers Squibb Company Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
CN108982465B (zh) * 2018-06-06 2020-10-02 上海应用技术大学 酒中二氧化硫高通量sers在线检测方法
CA3121202A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
WO2021113362A1 (en) * 2019-12-03 2021-06-10 Kallyope, Inc. Sstr5 antagonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8401907A (nl) * 1983-06-27 1985-01-16 Sandoz Ag Spirosuccinimiden en werkwijzen voor het bereiden en toepassen van deze spirosuccinimiden.
JP2001526178A (ja) 1997-08-28 2001-12-18 メルク エンド カムパニー インコーポレーテッド ピロリジン系およびピペリジン系ケモカイン受容体活性調節剤
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
WO2000051609A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
AU3386700A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
WO2001030780A2 (en) 1999-10-27 2001-05-03 Cor Therapeutics, Inc. Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
JP2002095730A (ja) 2000-07-21 2002-04-02 Midori Anzen Co Ltd 脱臭材及びその製造方法
EP1326619A2 (de) 2000-10-11 2003-07-16 Merck & Co., Inc. Pyrrolidin-modulatoren der ccr5-chemokin-rezeptor-aktivität
RU2315051C2 (ru) * 2001-12-28 2008-01-20 Акадиа Фармасьютикалз, Инк. Спироазациклические соединения, способ ингибирования активности или активации серотонинового 5-нт2а рецептора, способ лечения болезненного состояния, связанного с серотониновым 5-нт2а рецептором, и их применение
WO2004058763A1 (en) 2002-12-23 2004-07-15 Merck & Co., Inc. 4(spiropiperidinyl)methyl substituted pyrrolidines as modulators of chemokine receptor activity
WO2004058702A2 (en) 2002-12-23 2004-07-15 Merck & Co., Inc. 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity

Also Published As

Publication number Publication date
CA2579608A1 (en) 2005-03-17
US20050070563A1 (en) 2005-03-31
EP1786815B1 (de) 2011-08-24
EP1786815A1 (de) 2007-05-23
US7288548B2 (en) 2007-10-30
EP1786815A4 (de) 2009-03-18
WO2005023809A1 (en) 2005-03-17

Similar Documents

Publication Publication Date Title
SE9900100D0 (sv) New compounds
SE0202483D0 (sv) Chemical compounds
DK1501507T3 (da) Tetrahydropyranyl-cyclopentyl-tertrahydropyridopyrindin-modulatorer af kemokin-receptor-aktivitet
DE60112974D1 (en) Carbolinderivate
IS2416B (is) Pýrrólídíndíónútskipt píperídín-þalasón sem PDE4 tálmar
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
BR0014352A (pt) Cetoenóis espirocìclicos substituìdos por trifluormetila
DE60216233D1 (en) Carbolinderivate
GEP20074210B (en) Tropane derivatives as ccr5 modulators
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
MXPA03002911A (es) Compuestos quimicos.
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
SE0200919D0 (sv) Chemical compounds
ATE521610T1 (de) Spiroverbindungen und -verfahren zur modulation von chemokin-rezeptor-aktivität
ATE354622T1 (de) Flüssigkristallines medium
ATE498600T1 (de) Inden derivate als pharmazeutika
SE0103710D0 (sv) Compounds
BR0307903A (pt) derivados de arilsulfona
CY1111432T1 (el) Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5
DE60327936D1 (de) Modulatoren von ship-1
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
SE9903290D0 (sv) Novel compounds
EA200301101A1 (ru) Производные пиперазина и их применение в качестве ингибиторов pde4

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties